tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CERO Stock Latest News

Cero Therapeutics appoints Eric Francois to board of directors
The FlyCero Therapeutics appoints Eric Francois to board of directors
3d ago
CERO
SCYX
CERo Therapeutics Announces Convertible Note Financing and New Director
PremiumCompany Announcements
CERo Therapeutics Announces Convertible Note Financing and New Director
7d ago
8K
CERO
Cero Therapeutics to present data from Phase 2 trial of CER-1236
PremiumThe Fly
Cero Therapeutics to present data from Phase 2 trial of CER-1236
16d ago
CERO
CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial
PremiumCompany Announcements
CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial
16d ago
8K
CERO
CERo Therapeutics reports encouraging early CERTAINT-1 trial data
PremiumCompany Announcements
CERo Therapeutics reports encouraging early CERTAINT-1 trial data
1M ago
8K
CERO
Cero Therapeutics provides update on Phase 1 trial of CER-1236
PremiumThe FlyCero Therapeutics provides update on Phase 1 trial of CER-1236
1M ago
CERO
CERo Therapeutics shareholders approve key capital structure changes
Premium
Company Announcements
CERo Therapeutics shareholders approve key capital structure changes
2M ago
8K
CERO
Cero Therapeutics provides update on Phase 1 trial of CER-1236
Premium
The Fly
Cero Therapeutics provides update on Phase 1 trial of CER-1236
2M ago
CERO
CERo Therapeutics Enters New $14.6M Stock Agreement
PremiumCompany Announcements
CERo Therapeutics Enters New $14.6M Stock Agreement
3M ago
8K
CERO
Cero Therapeutics announces trading on OTCQB Market
PremiumThe Fly
Cero Therapeutics announces trading on OTCQB Market
3M ago
CERO
Cero Therapeutics downgraded to Hold from Buy at D. Boral Capital
PremiumThe Fly
Cero Therapeutics downgraded to Hold from Buy at D. Boral Capital
3M ago
CERO
CERo Therapeutics Delays Quarterly Report Filing
PremiumCompany Announcements
CERo Therapeutics Delays Quarterly Report Filing
3M ago
CERO
Cero Therapeutics initiates second cohort in Phase 1 trial of CER-1236
PremiumThe FlyCero Therapeutics initiates second cohort in Phase 1 trial of CER-1236
4M ago
CERO
Cero Therapeutics to present data on CER-1236 at SITC conference
Premium
The Fly
Cero Therapeutics to present data on CER-1236 at SITC conference
4M ago
CERO
Cero Therapeutics announces listing on OTC Markets
Premium
The Fly
Cero Therapeutics announces listing on OTC Markets
4M ago
CERO
Cero Therapeutics downgraded to Hold from Buy at Maxim
PremiumThe Fly
Cero Therapeutics downgraded to Hold from Buy at Maxim
4M ago
CERO
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
4M ago
FI
MA
Why Is CERo Therapeutics Stock Down 80% Today?
PremiumMarket News
Why Is CERo Therapeutics Stock Down 80% Today?
4M ago
CERO
CERo Therapeutics Faces Nasdaq Delisting Suspension
PremiumCompany Announcements
CERo Therapeutics Faces Nasdaq Delisting Suspension
4M ago
8K
CERO
Cero Therapeutics discloses Nasdaq Panel listing determination
PremiumThe FlyCero Therapeutics discloses Nasdaq Panel listing determination
4M ago
CERO
Cero Therapeutics’ Innovative AML Treatment Study: A Potential Game-Changer?
Premium
Company Announcements
Cero Therapeutics’ Innovative AML Treatment Study: A Potential Game-Changer?
4M ago
CERO
Cero announces third dose for patients in Phase 1 trial of CER-1236
Premium
The Fly
Cero announces third dose for patients in Phase 1 trial of CER-1236
4M ago
CERO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >